Chemours (CC) | Stock Overview & Key Data
Chemours Performance Comparison
Stock Range
Today's Range
Low: $14.10
High: $15.54
on August 22, 2025
52 Week Range
Low: $9.13
High: $22.38
on June 2, 2025
on November 27, 2024
All-Time High: $58.08 on October 23, 2017
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.2B
EPS
-2.74
P/E Ratio (TTM)
67.83
Forward P/E
6.33
P/B Ratio
9.24
PEG Ratio
-0.11
Div. Yield
6.82%
ROE
-85.27%
Beta
1.590
Debt to Equity
1,845.61
Financial Highlights
Profitability
Gross Margin
17.21%
Operating Margin
4.46%
Profit Margin
-7.04%
Returns and Earnings
Return on Assets (TTM)
2.98%
Return on Equity (TTM)
-85.27%
EBITDA
$801.0M
Net Income (TTM)
$-412.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$39.15
Quarterly Revenue Growth (YoY)
3.90%
Quarterly Earnings Growth (YoY)
5.01%
Dividend Information
Last 12-Month Dividend
$0.75
Current Dividend Yield
6.82%
3-Year Average Dividend Yield
1.03%
3-Year Average Annual Dividend
$0.83
3-Year Total Dividends
$2.50
Ex-Dividend Date
February 28, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Chemours CC | 2.19B Mid-cap | -6.10% | 4.27% | 34.25% | -15.57% | -15.32% | -26.68% | -60.43% | -32.52% |
| Linde plc LIN | 222.60B Mega-cap | 0.64% | 2.19% | 5.53% | 4.96% | 16.07% | 3.21% | 67.93% | 89.58% |
| Sherwin-Williams SHW | 91.45B Large-cap | -0.47% | 6.61% | 2.80% | 5.60% | 9.21% | 1.43% | 54.37% | 61.50% |
| Albemarle ALB | 9.85B Mid-cap | 8.89% | 17.38% | 36.26% | -1.66% | -3.57% | 3.55% | -69.56% | -8.41% |
| Eastman Chemical EMN | 7.58B Mid-cap | -0.59% | -14.80% | -18.99% | -33.13% | -25.43% | -34.51% | -30.55% | -11.31% |
| NewMarket NEU | 7.41B Mid-cap | 4.49% | 10.44% | 24.23% | 45.97% | 56.82% | 42.21% | 178.37% | 117.49% |
Ownership & Short Interest
Insider Ownership
0.47%
Institutional Ownership
101.24%
Shares Short
15M
Short Ratio
3.67
Short % of Shares Outstanding
14.60%
Average 10-Day Volume
5M
Average 90-Day Volume
4M
Chemours Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Chemours would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CC's 52-week high and low?
- In the last 52 weeks, Chemours reached a high of $22.38 (on November 27, 2024) and a low of $9.13 (on June 2, 2025).
- What is the market cap and P/E ratio for CC?
- Curious about Chemours's size and valuation? Its market capitalization stands at 2.19B. When it comes to valuation, the P/E ratio (trailing twelve months) is 67.83, and the forward P/E (looking ahead) is 6.33.
- Does CC pay dividends? If so, what's the yield?
- Yes, Chemours is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 6.82%, and the company has paid an average of $0.83 per share annually over the past 3 years.
- Who are Chemours's main competitors or similar companies to consider before investing?
When looking at Chemours, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Linde plc
LIN222.60B Basic Materials Specialty Chemicals 3.21% 67.93% Sherwin-Williams
SHW91.45B Basic Materials Specialty Chemicals 1.43% 54.37% Albemarle
ALB9.85B Basic Materials Specialty Chemicals 3.55% -69.56% Eastman Chemical
EMN7.58B Basic Materials Specialty Chemicals -34.51% -30.55% NewMarket
NEU7.41B Basic Materials Specialty Chemicals 42.21% 178.37% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Chemours Co.? (e.g., ROE, Debt/Equity)
- To get a sense of Chemours's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -85.27%, the Debt to Equity ratio from the most recent quarter is 1,845.61, and its Gross Profit Margin stands at 17.21%.
- What is the recent revenue and earnings growth for CC?
- Looking at Chemours's growth, its revenue over the trailing twelve months (TTM) was $6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.90%, and quarterly earnings saw a YoY growth of 5.01%.
- How much of CC stock is held by insiders and institutions?
- Wondering who owns Chemours stock? Company insiders (like executives and directors) hold about 0.47% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 101.24%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.